Deep dry needling of trigger points located in the lateral pterygoid muscle: Efficacy and safety of treatment for management of myofascial pain and temporomandibular dysfunction

To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. Forty-eight patients with chronic myofascial pain located in the LPM were selected and...

Full description

Saved in:
Bibliographic Details
Published in:Medicina oral, patología oral y cirugía bucal patología oral y cirugía bucal, 2015-05, Vol.20 (3), p.e326-e333
Main Authors: Gonzalez-Perez, Luis-Miguel, Infante-Cossio, Pedro, Granados-Nunez, Mercedes, Urresti-Lopez, Francisco-Javier, Lopez-Martos, Ricardo, Ruiz-Canela-Mendez, Pablo
Format: Article
Language:English
Subjects:
Acetaminophen - therapeutic use
Acupuncture Points
Acupuncture Therapy - instrumentation
Acupuncture Therapy - methods
Adolescent
Adult
Aged
Analgesics, Non-Narcotic - therapeutic use
Dentistry
Equipment Design
Female
Humans
Male
Methocarbamol - therapeutic use
Middle Aged
Muscle Relaxants, Central - therapeutic use
Myofascial Pain Syndromes - therapy
Needles
Pain Management - methods
Pterygoid Muscles
Temporomandibular Joint Disorders - therapy
Treatment Outcome
Trigger Points
Young Adult
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To determine whether deep dry needling (DDN) of trigger points (TPs) in the lateral pterygoid muscle (LPM) would significantly reduce pain and improve function, compared with methocarbamol/paracetamol medication. Forty-eight patients with chronic myofascial pain located in the LPM were selected and randomly assigned to one of two groups (DDN test group, n=24; drug-treated control group, n=24). The test group received three applications of needling of the LPM once per week for three weeks, while control group patients were given two tablets of a methocarbamol/paracetamol combination every six hours for three weeks. Assessments were carried out pre-treatment, 2 and 8 weeks after finishing the treatment. A statistically significant difference (p
ISSN:1698-6946
1698-4447
1698-6946
DOI:10.4317/medoral.20384